Wednesday 19th April, 2023

18:00 - 20:00
The Reception

An exclusive Reception hosted by H.E. the Ambassador of Sweden to the UK. Further details will be sent to delegates who are registered to attend the Anglonordic conference. Find out more...

Thursday 20th April, 2023

1:1 meetings will take place throughout the day and are pre-booked online.

08:15 - 09:00
Registration
09:00 - 09:05
Welcome
Mary Clark Managing Director Optimum Strategic Communications
Mattias Johansson, CEO Ezenze Ltd.

Morning Session

Chaired by Mary Clark, Managing Director, Optimum Strategic Communications.

09:05 - 09:30
Keynote
Joern-Peter Halle Head of Strategy & BD Merck
09:30 - 10:30
Panel Discussion: Trends in Life Science Investments

Europe’s leading investors will provide an overview of their outlook on the market, as well as current and future trends that are driving investment in the healthcare sector. Expect an insightful discussion around why some areas are so popular, challenges & opportunities around investing in these spaces plus horizon scanning for the year ahead.

Chair: Stephen Hansen Director of Biopharma Intelligence BioCentury
Hakan Goker Managing Director M Ventures
Henrijette Richter Managing Partner Sofinnova Partners
Roel Bulthuis Managing Partner Syncona
Christian Elling Managing Partner LundbeckFonden BioCapital

10:30 - 11:00
Coffee Break, Exhibition, Networking
11:00 - 12:15
Company Presentations - click links to view presentations

Biotechnology Room: drug discovery and delivery companies in all therapeutic areas.

Chaired by Donna Hackett Head of Commercial Translation Francis Crick Institute

Presenting Companies: 

PharmaHoldings

MetalloBio

OncoBone Ventures

NanoSyrinx

Monument TX

SentaurBio

Technology Room: medical devices, diagnostics, platform technologies and healthcare related product development

Chaired by Oliver HardickEntrepreneur in Residence M Ventures

Presenting Companies: 

LightOx

Diagonal Bio

Invizius

Microplate Dx

Genopore

Probmet

12:15 - 13:00
Lunch, Exhibition, Networking

Afternoon Session

Chaired by Mary Clark, Managing Director, Optimum Strategic Communications.

13:00 - 13:45
Panel Discussion: How Artificial Intelligence is Transforming Drug Discovery, Design, and Development

A panel of industry experts and investors will discuss this exciting new field that is now starting to influence all aspects of new medicine discovery. Expect honest insights, and discussions on the rapid advances that have been made and the technologies being developed.

Chair: Kevin Grogan Managing Editor, Europe Scrip
Mati Gill CEO AION Labs
Danuta Jeziorska CEO Nucleome Therapeutics
Olivia Cavlan Chief Corporate Development & Strategy Officer Alchemab Therapeutics
Yann Gaston-Mathe CEO Iktos
Jeremy Skillington CEO Poolbeg Pharma
13:45 - 15:10
Company Presentations

Biotechnology Room: drug discovery and delivery companies in all therapeutic areas.

Chaired by Hollie Vile Optimum Communications

Presenting Companies: 

ImaginAb

Lytix Biopharma

Concerto Biosciences

InProTher

Versameb

Leucid Bio

Microviable Therapeutics

Technology Room: medical devices, diagnostics, platform technologies and healthcare related product development

Chaired by Noga Yerushalmi Investment Director M Ventures

Presenting Companies: 

Actithera

Samsara Therapeutics

Theolytics

Cbio

Limnopharma

Quibim 

15:10 - 15:40
Coffee Break, Exhibition, Networking
15:40 - 16:25
Panel Discussion: Fundraising Ecosystem for Life Sciences Tools and Tech: Development, Challenges, Future


Chair: Oliver Hardick Entrepreneur in Residence M Ventures
Sean Kendall Partner (Europe) Arch Venture Partners
Richard Vellacot CEO BiologIC Technologies
Paul Loeffen CEO Lightcast
Kieran Murphy Chairman Gamma Biosciences
16:25 - 17:25
Panel Discussion: If I knew then what I know now

In this Anglonordic staple, Mike Ward returns to chair our panel of industry executives who will reflect on previous experiences and discuss key learnings from their careers.

Chair: Mike Ward, Global Head of Life Sciences & Healthcare Thought Leadership Clarivate
Stephanie Leouzon Managing Director, Health Care Investment Banking Stifel
Niall Martin CEO Artios
Dan Mahony Chairman UK BioIndustry Association (BIA)
Eva Lotta-Allan Chair Draupnir Bio
17:25 - 17:35
Conclusions
Reflections on the days themes and topics by: 

Hakan Goker Managing Director M Ventures
Mary Clark Managing Director Optimum Strategic Communications

17:35 - 17:45
Charity of the Year - Beacon for Rare Diseases
Laura Thompson-Harper Fundraising Manager
Faith Walpole Fundraising Officer
17:45 
18:45
Drinks Reception - sponsored by Biotech Business Institute

Host:

Juan R. Garcia Board Chairman, Biotech Business Institute